BioSpace News Archive

Segra International Corp. (“Segra”) is pleased to announce that it has entered into a strategic plant genotyping and tissue culture agreement with Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.RT) (“Sugarbud”) through its wholly owned subsidiary Segra Biogenesis Corp

As part of its R&D Day on December 5, 2019, Novartis highlighted the progress that has been made on iscalimab (CFZ533), a product candidate, for which XOMA (NASDAQ: XOMA) has the potential to earn royalties that are tiered from a mid-single to a low teens percentage rate based on sales levels, if this investigational compound is approved and commercialized.

Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that new data on its lead immuno-oncology candidate asunercept will be presented in a poster at the ESMO Immuno-Oncology Congress 2019, held from December 11-14, 2019, at the Palexpo in Geneva, Switzerland.

The U.S. Food and Drug Administration has been investigating the presence of genotoxic impurities, called nitrosamines, in some types of drugs.

Medicure Inc., a cardiovascular pharmaceutical company, announced that it has reached a settlement agreement with the purchaser of Medicure’s interests in Apicore with respect to the amounts heldback under the Apicore sale agreement.

The Canadian Medical Association is pleased to see Speech from the Throne reflect the need to increase our support for health care in Canada.

Health Canada is aware that some metformin products available outside Canada have been found to contain a nitrosamine impurity, N-nitrosodimethylamine, above the acceptable limit.

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) named Anne Esposito as senior vice president of federal advocacy, effective January 2020

As radiology professionals gather at the 2019 Radiology Society of North America (RSNA) Annual Meeting, Bayer Radiology is helping to support the expansion of imaging in developing countries through a comprehensive product donation.

RB and Evolve BioSystems announce a partnership in the sale of Evivo®, Evolve BioSystems’ infant probiotic.